Mutant TP53 clones

Biomarker1 paper1 finding

  • Humans1

Interventions

1

Cross regimen

upin humans1Very low certainty

1 study

  1. Cross regimen increases mutant TP53 clones in humans.

    Humanspatients undergoing CROSS (chemotherapy and radiation therapy)

    Cancer treatment alters mutant selection in normal esophagus · Nature genetics · 11 Sep 2026

Cross regimen →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01

Related